Distribution deal for Middle East boosts Advicenne shares

Advicenne SA

28/06/2022 08:34

** Shares in Advicenne  ALDVI.PA  rise about 4%, paring
earlier gains of nearly 8%, after the French biopharmaceutical
company signed a distribution agreement for Sibnayal for the
Middle East
    ** The deal with Taiba Healthcare will cover the
commercialisation of Sibnayal, Advicenne's treatment for distal
renal tubular acidosis, a kidney disease, in Saudi Arabia, UAE,
Oman, Kuwait, Qatar and Bahrain  urn:newsml:reuters.com:*:nFWN2YF02U
    ** Advicenne said it would receive a transfer price and
royalties for an amount "markedly higher" than 50% of future
sales of Sibnayal
    ** Up to the previous session's close, Advicenne shares were
down 38.9%​ year-to-date
    

 (Reporting by Valentine Baldassari)
 ((Valentine.baldassari@tr.com))